Sudeep Pharma IPO Details
The Sudeep Pharma IPO is a book build issue with a total issue size of ₹895 cr, comprising of fresh issue of 1602024 equity shares., and a offer for sale of 13490726 equity shares. Sudeep Pharma IPO opened for subscription on Nov 21, 2025 and closed on Nov 25, 2025. Sudeep Pharma IPO is set price band at ₹563 to ₹593 per share, with a lot size of 25 shares. Minimum investment for Retail investors was ₹14,825.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Nov 26, 2025, and listed on both the NSE and BSE on Nov 28, 2025.
MUFG Intime India Private Limited has been appointed as the registrar. ICICI Securities Limited and IIFL Capital Services Limited are the Book Running Lead Manager for the issue.
Before investing in the Sudeep Pharma IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 563 – 593
- Lot Size
- 25
- Issue Size
- ₹895 Cr
- Minimum Investment
- ₹14825 (25 Shares)
- Listing Date
- 28 November 2025
Current GMP
₹121 (+20.40%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Sudeep Pharma Limited
Sudeep Pharma Limited, incorporated in 1989, is a leading manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, supplying products to over 100 countries.
Operations
- The company operates six manufacturing facilities with a combined production capacity of 50,000 MT.
- It specializes in producing high-quality mineral salts, including calcium, iron, magnesium, zinc, potassium, and sodium derivatives.
- With a portfolio of more than 200 products, Sudeep Pharma serves a diverse clientele across the pharmaceutical, food, and nutrition industries.
Research & Development
- The company has strong R&D capabilities supported by in-house laboratories and pilot-scale production facilities.
- Its R&D efforts focus on innovation in mineral salts, pharmaceutical excipients, and specialty ingredients.
Product Portfolio
- Pharmaceutical, Food, and Nutrition Business
- Specialty Ingredients Business
- Triturates
Human Resources
- As of December 31, 2024, Sudeep Pharma Limited employed 704 permanent employees.
Sudeep Pharma IPO Promoters
- Sujit Jaysukh Bhayani
- Shanil Sujit Bhayani
- Avani Sujit Bhayani
- Sujeet Jaysukh Bhayani HUF
- Riva Resources Private Limited
- Bhayani Family Trust
Promoters Holding
Holding Pre Issue
89.37%
Holding Post Issue
76.15%
Sudeep Pharma IPO Objective
The Company Sudeep Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Capital expenditure towards procurement of machinery for our production line located at Nandesari Facility I
- General corporate purpose
Address / Contact Info
Sudeep Pharma Ltd.
129/1/A,
GIDC Estate,Nandesari,
Vadodara, Gujarat, 391340
Phone: +91 265 284 0656
Email: cs.sudeep@sudeepgroup.com
Website: https://www.sudeeppharma.com/
IPO Snapshot
Book Running Lead Managers
- ICICI Securities Limited
- IIFL Capital Services Limited
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Sudeep Pharma IPO is a Book-building IPO with a total issue size of ₹895 crore. The Sudeep Pharma IPO price band is ₹563 to 593 per share. The Sudeep Pharma IPO subscription opens on Fri, Nov 21, 2025, and closes on Tue, Nov 25, 2025. The Sudeep Pharma IPO will be listed on the BSE,NSE. MUFG Intime India Private Limited is the registrar for the Sudeep Pharma IPO.
The Sudeep Pharma IPO opens on Fri, Nov 21, 2025 and closes on Tue, Nov 25, 2025
Sudeep Pharma IPO Price Band is ₹563 to 593 per share.
Sudeep Pharma IPO lot size is 25 shares, Retail investors need a minimum investment of ₹14825 based on the upper price band
The minimum investment for Sudeep Pharma IPO is ₹14825, based on one lot of 25 shares at the upper price band of ₹593 per share.
Investors can apply for the Sudeep Pharma IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Nov 25, 2025. The application amount remains blocked until the Sudeep Pharma IPO allotment is finalized.
Sudeep Pharma IPO issue size is ₹895 crores.
Sudeep Pharma IPO allotment date is Wed, Jul 1, 2026.
The registrar for Sudeep Pharma IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited website to check Sudeep Pharma IPO allotment status, refund processing, and other IPO-related information.
The Sudeep Pharma IPO GMP (Grey Market Premium) is ₹121 as of Fri, Nov 28, 2025. Based on the upper price band of ₹593 per share, the estimated Sudeep Pharma IPO listing price is ₹714, indicating a potential listing gain of approximately 0% over the issue price.